Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 9 results
Author Title Type [ Year(Asc)]
Filters: Keyword is Leishmaniasis, Visceral  [Clear All Filters]
2017
Murray HW, Luster AD, Zheng H, Ma X.  2017.  Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.. Infect Immun. 85(1)
2015
Murray HW, Mitchell-Flack M, Zheng H, Ma X.  2015.  Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.. Infect Immun. 83(2):702-12.
Murray HW, Mitchell-Flack M, Taylor GA, Ma X.  2015.  IFN-γ-induced macrophage antileishmanial mechanisms in mice: A role for immunity-related GTPases, Irgm1 and Irgm3, in Leishmania donovani infection in the liver.. Exp Parasitol. 157:103-9.
2013
Murray HW, Zhang Y, Zhang Y, Raman VS, Reed SG, Ma X.  2013.  Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver.. Infect Immun. 81(7):2318-26.
2006
Murray HW, Xiang Z, Ma X.  2006.  Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase.. Am J Trop Med Hyg. 74(6):1013-5.
Murray HW, Tsai CW, Liu J, Ma X.  2006.  Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18.. Infect Immun. 74(7):4370-4.
Murray HW, Tsai CW, Liu J, Ma X.  2006.  Visceral Leishmania donovani infection in interleukin-13-/- mice.. Infect Immun. 74(4):2487-90.
2005
Murray HW, Flanders KC, Donaldson DD, Sypek JP, Gotwals PJ, Liu J, Ma X.  2005.  Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.. Infect Immun. 73(7):3903-11.
2003
Murray HW, Moreira AL, Lu CM, DeVecchio JL, Matsuhashi M, Ma X, Heinzel FP.  2003.  Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.. J Infect Dis. 188(3):458-64.